zolpidem has been researched along with Disease Models, Animal in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 9 (34.62) | 29.6817 |
2010's | 12 (46.15) | 24.3611 |
2020's | 3 (11.54) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Allocca, G; Chu, J; Cornthwaite-Duncan, L; Daykin, H; Hoyer, D; Jacobson, LH; Keenan, RJ | 1 |
Pick, CG; Schreiber, S | 1 |
Chae, SW; Choi, HY; Chun, SW; Lee, YT; Oh, MK; Park, YH; Park, YS; Shin, HS; Yoon, KJ | 1 |
Cortopassi, GA; Datta, S; McMackin, MZ; Yu, AK | 1 |
Cain, P; Franke, TF; Hoeffer, CA; Krishnamurthy, P; Levenga, J; Rajamohamedsait, H; Sigurdsson, EM; Wong, H | 1 |
El Zahaf, NA; Salem Elhwuegi, A | 1 |
Catterall, WA; Han, S; Jones, CJ; Scheuer, T; Tai, C | 1 |
Auta, J; Costa, E; Guidotti, A; Impagnatiello, F; Kadriu, B | 1 |
Hutson, PH; Ivarsson, M; Nutt, DJ; Paterson, LM; Wilson, SJ | 2 |
Buck, KJ; Kozell, LB; Milner, LC; Walter, NA; Wickman, K | 1 |
Matsuta, Y; Ohtake, A; Sasamata, M; Suzuki, M; Watanabe, M; Yanai-Inamura, H; Yokoyama, O | 1 |
Pericić, D; Vlainić, J | 1 |
Heldt, SA; Ressler, KJ | 1 |
Baghdoyan, HA; Gauthier, EA; Hambrecht-Wiedbusch, VS; Lydic, R | 1 |
Asato, M; Furuya, M; Imai, S; Konno, M; Kuzumaki, N; Matoba, M; Matsushima, Y; Miyoshi, K; Nanjo-Niikura, K; Narita, M; Niikura, K; Okutsu, D; Saeki, M; Shimizu, T; Suzuki, M; Suzuki, T; Tsukiyama, Y; Yamashita, A; Yomiya, K | 1 |
Nag, N; Storey, E; Tarlac, V | 1 |
Fernandes-Santos, L; Frussa-Filho, R; Oliveira, LC; Patti, CL; Poyares, D; Sanday, L; Tufik, S; Zanin, KA | 1 |
Bjerrum, OJ; Blackburn-Munro, G; Jensen, DG; Rode, F | 1 |
Mathiasen, L; Mirza, NR | 1 |
Holopainen, IE; Kukko-Lukjanov, TK; Laurén, HB; Lopez-Picon, FR; Uusi-Oukari, M | 1 |
Pericić, D; Strac, DS; Vlainić, J | 1 |
Bertram, EH; Mangan, PS | 1 |
Defazio, RA; Hablitz, JJ | 2 |
1 trial(s) available for zolpidem and Disease Models, Animal
Article | Year |
---|---|
A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.
Topics: Adult; Animals; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Electromyography; GABA Agonists; Humans; Hypnotics and Sedatives; Male; Polysomnography; Pyridines; Rats; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Telemetry; Trazodone; Zolpidem | 2007 |
25 other study(ies) available for zolpidem and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
Topics: Animals; Azepines; Disease Models, Animal; Female; Hypnotics and Sedatives; Male; Mice; Mice, Transgenic; Sex Characteristics; Sleep; Sleep Wake Disorders; Tauopathies; Triazoles; Zolpidem | 2022 |
Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep?
Topics: Analgesics; Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Mirtazapine; Naloxone; Receptors, Opioid; Serotonin; Sleep; Sleep Wake Disorders; Trazodone; Zolpidem | 2020 |
Effect of zolpidem on functional recovery in a rat model of ischemic stroke.
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Drug Administration Schedule; GABA-A Receptor Agonists; Gene Expression; Injections, Intraperitoneal; Magnetic Resonance Imaging; Male; Maze Learning; Neuroimaging; Neuronal Plasticity; Neuroprotective Agents; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke; Zolpidem | 2018 |
Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules.
Topics: Animals; Disease Models, Animal; DNA, Mitochondrial; Electron Transport Complex I; Glaucoma, Open-Angle; Humans; Inflammation; Mediator Complex; Mice; Mice, Knockout; Mitochondria; Mitochondrial Diseases; Optic Nerve Diseases; Papaverine; Pyridines; Retinal Ganglion Cells; Zolpidem | 2017 |
Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.
Topics: Animals; Cell Count; Cerebral Cortex; Disease Models, Animal; GABA-A Receptor Agonists; GABAergic Neurons; Hippocampus; Humans; Interneurons; Long-Term Potentiation; Mice, Inbred C57BL; Mice, Transgenic; Pyridines; Sensory Gating; tau Proteins; Tauopathies; Zolpidem | 2013 |
The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.
Topics: Alprazolam; Animals; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Hypokinesia; Imipramine; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pyridines; Stress, Psychological; Swimming; Time Factors; Vigabatrin; Zolpidem | 2014 |
Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Benzodiazepines; Brain; Disease Models, Animal; Fluorobenzenes; Interpersonal Relations; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Protein Subunits; Pyridines; Receptors, GABA-A; Social Behavior; Synaptic Transmission; Triazoles; Zolpidem | 2014 |
Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem.
Topics: Animals; Anticonvulsants; Behavior, Animal; Benzodiazepines; Bicuculline; Diazepam; Differential Threshold; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; GABA Modulators; Imidazoles; Male; Pyridines; Rats; Rats, Inbred F344; Seizures; Zolpidem | 2008 |
Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Topics: Animals; Body Temperature; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Electroencephalography; Electromyography; Hypnotics and Sedatives; Male; Motor Activity; Pyridines; Rats; Rats, Sprague-Dawley; Sleep; Sleep Initiation and Maintenance Disorders; Telemetry; Trazodone; Zolpidem | 2009 |
Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol.
Topics: Animals; Area Under Curve; Behavior, Animal; Brain; Chromosome Mapping; Chromosomes, Human, Pair 1; Disease Models, Animal; DNA Mutational Analysis; Ethanol; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Pentobarbital; Polymorphism, Single Nucleotide; Pyridines; Quantitative Trait Loci; Substance Withdrawal Syndrome; Zolpidem | 2009 |
Zolpidem increases bladder capacity and decreases urine excretion in rats.
Topics: Aldosterone; Animals; Bicuculline; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; GABA Agonists; GABA Antagonists; Infarction, Middle Cerebral Artery; Injections, Intravenous; Pyridines; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Rats, Wistar; Time Factors; Urinary Bladder; Urinary Bladder, Overactive; Urination; Urodynamics; Zolpidem | 2010 |
Zolpidem is a potent anticonvulsant in adult and aged mice.
Topics: Age Factors; Aging; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; GABA Agonists; Male; Mice; Motor Activity; Pentylenetetrazole; Pyridines; Seizures; Zolpidem | 2010 |
Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice.
Topics: Amygdala; Animals; Animals, Newborn; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cell Line, Transformed; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Exploratory Behavior; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; Humans; Hypnotics and Sedatives; Locomotion; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pentylenetetrazole; Pyridines; Receptors, GABA-A; RNA, Messenger; Transfection; Zolpidem | 2010 |
Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.
Topics: Acetylcholine; Animals; Azabicyclo Compounds; Brain; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Eszopiclone; GABA Agonists; GABA-A Receptor Agonists; Hypnotics and Sedatives; Male; Microdialysis; Piperazines; Pons; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reticular Formation; Sleep Stages; Zolpidem | 2010 |
Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex.
Topics: Analysis of Variance; Animals; Anisoles; Disease Models, Animal; Electroencephalography; Electromyography; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gyrus Cinguli; Hyperalgesia; Hypnotics and Sedatives; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Microdialysis; Midazolam; Nipecotic Acids; Pain Measurement; Pain Threshold; Physical Stimulation; Pyridines; Reflex; RNA, Messenger; Sciatic Neuropathy; Sleep Wake Disorders; Zolpidem | 2011 |
Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.
Topics: Amantadine; Animals; Ataxin-1; Ataxins; Buspirone; Disease Models, Animal; Dopamine Agents; Genotype; Hypnotics and Sedatives; Kyphosis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Phenotype; Purkinje Cells; Pyridines; Riluzole; Serotonin Receptor Agonists; Spinocerebellar Ataxias; Zolpidem | 2013 |
Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Male; Maze Learning; Memory; Mice; Pyridines; Time Factors; Zolpidem | 2013 |
Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Agonists; GABA-A Receptor Agonists; Isonicotinic Acids; Isoxazoles; Male; Muscimol; Neuralgia; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Stress, Mechanical; Time Factors; Trauma, Nervous System; Zolpidem | 2005 |
A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepinones; Chlordiazepoxide; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drinking Behavior; Drug Interactions; Electroshock; Fluorobenzenes; GABA Agents; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pyridines; Reaction Time; Reproducibility of Results; Time Factors; Triazoles; Water Deprivation; Zolpidem | 2005 |
Status epilepticus alters zolpidem sensitivity of [3H]flunitrazepam binding in the developing rat brain.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Autoradiography; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Flunitrazepam; GABA Agonists; GABA Modulators; Kainic Acid; Protein Binding; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Status Epilepticus; Zolpidem | 2007 |
Sedative and anticonvulsant effects of zolpidem in adult and aged mice.
Topics: Age Factors; Animals; Anticonvulsants; Brain; Convulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Antagonism; Epilepsy; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Mice; Mice, Inbred CBA; Motor Activity; Pentylenetetrazole; Picrotoxin; Pyridines; Zolpidem | 2008 |
Shortened-duration GABA(A) receptor-mediated synaptic potentials underlie enhanced CA1 excitability in a chronic model of temporal lobe epilepsy.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Disease Models, Animal; Electric Stimulation; Epilepsy, Temporal Lobe; Evoked Potentials; GABA Antagonists; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; Hippocampus; Hypnotics and Sedatives; Male; Phosphinic Acids; Propanolamines; Pyramidal Cells; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, GABA-B; Regression Analysis; Synapses; Zolpidem | 1997 |
Reduction of zolpidem sensitivity in a freeze lesion model of neocortical dysgenesis.
Topics: Animals; Disease Models, Animal; Electric Stimulation; Electrophysiology; Excitatory Postsynaptic Potentials; Female; Freezing; GABA-A Receptor Agonists; Hypnotics and Sedatives; Membrane Potentials; Neocortex; Patch-Clamp Techniques; Pregnancy; Pyridines; Rats; Rats, Sprague-Dawley; Zolpidem | 1999 |
Altered receptor subunit expression in rat neocortical malformations.
Topics: Animals; Disease Models, Animal; Epilepsy; Excitatory Postsynaptic Potentials; Freezing; Neocortex; Neural Inhibition; Patch-Clamp Techniques; Piperidines; Pyridines; Rats; Receptors, GABA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Zolpidem | 2000 |